Yüklüyor......

Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention

There is an increasing appreciation that complement dysregulation lies at the heart of numerous immune-mediated and inflammatory disorders. Complement inhibitors are therefore being evaluated as new therapeutic options in various clinical translation programs and the first clinically approved comple...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Oral Microbiol
Asıl Yazarlar: Mastellos, Dimitrios C., Ricklin, Daniel, Hajishengallis, Evlambia, Hajishengallis, George, Lambris, John D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4712080/
https://ncbi.nlm.nih.gov/pubmed/26332138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/omi.12129
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!